powder for solution for infusion
Soluvit N is a medicine containing water-soluble vitamins, administered intravenously when oral nutrition is not possible. Vitamins are organic substances necessary in small amounts for the proper functioning of the body.
Soluvit N is indicated for use as a component of clinical nutrition, along with proteins, fats, carbohydrates, salts, and other vitamins.
Do not use Soluvit N:
In patients using Soluvit N, the doctor may order regular blood tests to check the patient's health.
Soluvit N contains 60 μg of biotin per vial (i.e., 6.0 μg per 1 ml after dilution). If the patient is to undergo laboratory tests, they should inform their doctor or laboratory staff that they have recently taken Soluvit N, as biotin may interfere with the results of such tests.
Depending on the test, the results may be falsely elevated or falsely low due to the presence of biotin.
The doctor may recommend stopping the use of Soluvit N before performing laboratory tests. It should also be remembered that other products that may be taken, such as multivitamin preparations or dietary supplements used to improve the condition of hair, skin, and nails, may also contain biotin and affect laboratory test results. If the patient is taking such products, they should inform their doctor or laboratory staff.
Tell your doctor or pharmacist about all medicines the patient is taking, has recently taken, or plans to take.
Tell your doctor:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine.
The doctor will decide whether to use Soluvit N in pregnant or breastfeeding women.
Soluvit N has no influence or negligible influence on the ability to drive and use machines.
Medicines containing methyl parahydroxybenzoate may cause allergic reactions (possible late reactions) and, exceptionally, bronchospasm (not observed with Soluvit N).
The dissolved and diluted Soluvit N is administered by intravenous infusion (drip infusion).
Dosing is determined by the doctor for each patient.
The usual daily dose for adult patients and children with a body weight of 10 kg or more is the contents of one vial (dissolved in 10 ml of solution).
Children with a body weight below 10 kg should receive 1 ml of the solution per kilogram of body weight per day.
The doctor or nurse will monitor the patient's health during the infusion, so the likelihood of administering a higher dose than recommended is low. However, if the patient believes they have received a higher dose of Soluvit N than recommended, they should immediately inform their doctor or nurse.
In case of any further doubts about using this medicine, consult your doctor or nurse.
Like all medicines, Soluvit N can cause side effects, although not everybody gets them.
Allergic reactions may occur, including severe anaphylactic reactions in patients hypersensitive to any component of Soluvit N, such as folic acid, thiamine, or methyl parahydroxybenzoate (frequency not known).
If side effects occur, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 (22) 49 21 301
fax: +48 (22) 49 21 309
website: https://smz.ezdrowie.gov.pl
Reporting side effects will help gather more information on the safety of this medicine.
The doctor or nurse is responsible for ensuring proper storage, use, and disposal of Soluvit N.
Do not store above 25°C. Store in the original packaging to protect from light.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Unused portions of the medicine are not suitable for further use.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The other ingredients (excipients) are: glycine, disodium edetate, methyl parahydroxybenzoate.
Osmolality in 10 ml of water: approximately 490 mOsm/kg of water, pH in 10 ml of water: 5.8.
Soluvit N is a yellow powder for solution for infusion.
After dissolution, each vial contains 10 ml of solution.
Soluvit N is available in glass vials, packaged in 10 pieces in a cardboard box.
For more detailed information, consult the marketing authorization holder or parallel importer:
Fresenius Kabi Nederland B.V.
Amersfoortseweg 10 E
3712 BC Huis ter Heide, Netherlands
Pfizer Puurs
2870 Puurs, Belgium
Fresenius Kabi
751 74 Uppsala
Sweden
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Netherlands marketing authorization number: RVG 09077
[Information on the trademark]
Soluvit N must not be administered undissolved.
If water solutions are used for dissolution, the mixture should be protected from light.
This is not necessary if Soluvit N is dissolved in a fat emulsion, such as Intralipid 10% or Intralipid 20%, due to the protective effect of the emulsion.
Dosage
Adult patients and children with a body weight of 10 kg or more
The contents of one vial cover the daily needs of adult patients and children with a body weight of 10 kg or more.
Children with a body weight below 10 kg
Children with a body weight below 10 kg should receive 1/10 of the vial contents/kg body weight/day.
Administration
Instructions for reconstitution of the medicine before administration, see section: Preparation of the medicine for use.
There are no reports of adverse reactions related to overdose of water-soluble vitamins, except for parenteral administration of very high doses.
There are no reports of overdose of medicines used as a supplement to meet the needs for water-soluble vitamins during parenteral nutrition.
No specific treatment is necessary.
During mixing with other medicines, aseptic rules should be followed.
Adult patients and children from 11 years of age
The contents of one vial of Soluvit N should be dissolved by adding 10 ml of one of the following medicines:
Soluvit N can be added to medicines used for parenteral nutrition containing carbohydrates, fats, amino acids, electrolytes, and trace elements, provided that pharmaceutical compatibility and stability of the resulting mixture have been confirmed.
Children up to 11 years of age
The contents of one vial of Soluvit N should be dissolved by adding 10 ml of one of the following medicines:
Children with a body weight below 10 kg should receive 1 ml of the resulting mixture/kg body weight/day.
Children with a body weight of 10 kg or more should receive 10 ml (one vial) of the medicine per day.
The mixture resulting from dissolving Soluvit N in Vitalipid N Infant is not recommended for use in children with a body weight below 10 kg due to differences in dosing.
Soluvit N can be added to medicines used for parenteral nutrition containing carbohydrates, fats, amino acids, electrolytes, and trace elements, provided that pharmaceutical compatibility and stability of the resulting mixture have been confirmed.
Do not mix the medicine with other medicines, except those listed in the section: Preparation of the medicine for use.
Do not store above 25°C. Store in the packaging. Protect from light.
Any unused medicine or waste material should be disposed of in accordance with local regulations.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.